ProfileGDS4814 / ILMN_1760556
TitleOvarian cancer xenograft tumor response to trastuzumab and pertuzumab
OrganismHomo sapiens


none trastuzumab pertuzumab trastuzumab and pertuzumab GSM780707 GSM780708 GSM780709 GSM780719 GSM780720 GSM780721 GSM780710 GSM780711 GSM780712 GSM780722 GSM780723 GSM780724 GSM780713 GSM780714 GSM780715 GSM780725 GSM780726 GSM780727 GSM780716 GSM780717 GSM780718 GSM780728 GSM780729 91% 93% 93% 92% 94% 93% 94% 93% 93% 94% 93% 94% 92% 92% 92% 92% 92% 91% 95% 93% 93% 93% 94% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM780707Untreated after 4 days (C1_1)483.81491
GSM780708Untreated after 4 days (C2_1)667.60493
GSM780709Untreated after 4 days (C3_1)599.58793
GSM780719Untreated after 4 days (C1_2)527.29592
GSM780720Untreated after 4 days (C2_2)758.31294
GSM780721Untreated after 4 days (C3_2)581.46993
GSM780710Trastuzumab treated after 4 days (T1_1)746.99794
GSM780711Trastuzumab treated after 4 days (T2_1)623.32793
GSM780712Trastuzumab treated after 4 days (T3_1)672.88793
GSM780722Trastuzumab treated after 4 days (T1_2)730.79794
GSM780723Trastuzumab treated after 4 days (T2_2)616.27793
GSM780724Trastuzumab treated after 4 days (T3_2)697.21194
GSM780713Pertuzumab treated after 4 days (P1_1)506.592
GSM780714Pertuzumab treated after 4 days (P2_1)547.31392
GSM780715Pertuzumab treated after 4 days (P3_1)542.95992
GSM780725Pertuzumab treated after 4 days (P1_2)520.65492
GSM780726Pertuzumab treated after 4 days (P2_2)505.96892
GSM780727Pertuzumab treated after 4 days (P3_2)487.9191
GSM780716Trastuzumab and Pertuzumab treated after 4 days (TP1_1)901.46995
GSM780717Trastuzumab and Pertuzumab treated after 4 days (TP2_1)614.23593
GSM780718Trastuzumab and Pertuzumab treated after 4 days (TP3_1)632.81393
GSM780728Trastuzumab and Pertuzumab treated after 4 days (TP1_2)631.72293
GSM780729Trastuzumab and Pertuzumab treated after 4 days (TP2_2)714.10494